Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
Aug 15, 2023
Legend Biotech to Host Investor Conference Call on Second-Quarter Results
Aug 03, 2023
Legend Biotech Announces Submission of Supplemental Application to the U.S...
Jun 06, 2023
Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression o..
Jun 05, 2023
Legend Biotech Announces Submission to the European Medicines Agency for Ex..
May 25, 2023
We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.